Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus acidophilus L-92 and Improved Immune Modulation

Research synthesisLow evidenceModerate effect5 studies · 5 beneficial · 0 neutral · 0 harmful

Across 5 studies, all reported beneficial effects of Lactobacillus acidophilus L-92 on immune modulation, with a predominant moderate effect size. Most evidence comes from reviews and animal studies, with one human-relevant study showing statistically significant increases in phagocytic activity and IFN-γ production. Doses and study durations were not consistently reported, limiting specificity.

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 5 studies) — conclusions should be considered preliminary. Most studies are reviews or animal-focused, with limited direct human trial data for the specific L-92 strain.

Generated May 12, 2026
5 of 5 papers
Back to top